[CIS PIDD] [cis-pidd] Heterozygous RAG1 mutation, isolated CD4 lymphopenia, warts and bone marrow hypoplasia

[CIS-PIDD]

Even with RAG functional testing, it still leaves the fact that this is heterozygous so there must be an enhancer/regulatory/splice site defect on the other allele for this to be meaningful.


I guess the question is about management and one possible answer would be BMT.  At 23y, his window of opportunity will only get smaller.

I wanted to post to just get on my soapbox to say that you don’t always need a gene.  We know WES misses a fair bit and while BMT may or may not be the right answer for this specific patient, I want to just say that we shouldn’t let our gene search and desire for mutations and other technical aspects let us delay therapy.  I know that wasn’t what was intended in the responses but it seemed like a good opportunity to say this important message again.

For warts specifically- we LOVE topical cidofovir.  Every expensive and often need to partner with other therapies but we LOVE it.

Kate



Kate Sullivan, MD PhD
Wallace Chair
Chief of Allergy Immunology
ARC 1216 CHOP
3615 Civic Center Blvd.
Philadelphia, PA 19104
(p) 215-590-1697
(f) 267-426-0363



On Feb 14, 2017, at 6:06 AM, CIS-PIDD <cis-pidd at lists.clinimmsoc.org<mailto:cis-pidd at lists.clinimmsoc.org>> wrote:

We have tested (and extensively published) on the recombination activity of more than 90 RAG1 genetic variants. Send me the specifics of the mutation and I may be able to tell you whether it is functionally relevant. No patient samples are needed for this.

Luigi D Notarangelo
Laboratory of Host Defenses
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Bldg 10 CRC, room 5-3950
10 Center Drive
Bethesda, MD 20817
USA
Luigi.notarangelo2 at nih.gov<mailto:Luigi.notarangelo2 at nih.gov>

Sent from my iPhone

On Feb 14, 2017, at 6:01 AM, CIS-PIDD <cis-pidd at lists.clinimmsoc.org<mailto:cis-pidd at lists.clinimmsoc.org>> wrote:

Dear Boaz,

Ad 3: Please contact Klaus Schwarz (cc), he will need fibroblasts to perform the assay.

Best wishes, St.


UNIVERSITÄTSKLINIKUM FREIBURG
Sektion Pädiatrische Immunologie (CCI)
Zentrum für Kinder- und Jugendmedizin

Prof. Dr. Stephan Ehl
Medizinischer Direktor CCI

Breisacher Straße 115 · 79106 Freiburg
Telefon: +49 (0)761 270-77300
Telefax: +49 (0)761 270-77744
stephan.ehl at uniklinik-freiburg.de<mailto:stephan.ehl at uniklinik-freiburg.de>

www.uniklinik-freiburg.de<http://www.uniklinik-freiburg.de/>
www.uniklinik-freiburg.de/cci<http://www.uniklinik-freiburg.de/cci>

Von: CIS-PIDD <cis-pidd at lists.clinimmsoc.org<mailto:cis-pidd at lists.clinimmsoc.org>>
Antworten an: CIS-PIDD <cis-pidd at lyris.dundee.net<mailto:cis-pidd at lyris.dundee.net>>
Datum: Dienstag, 14. Februar 2017 um 11:19
An: CIS-PIDD <cis-pidd at lyris.dundee.net<mailto:cis-pidd at lyris.dundee.net>>
Betreff: [cis-pidd] Heterozygous RAG1 mutation, isolated CD4 lymphopenia, warts and bone marrow hypoplasia

Dear all,

We are evaluating a 23yo male with idiopathic CD4 lymphopenia (~150-200 T CD4) clinically he presented with:
- generalized verrucosis (since age 16)
- slowly progressive signs of bone marrow hypoplasia: macrocytic anemia (Hb ~11, MCV 100), thrombocytopenia (Plt ~100.000), normal neutrophils. Hypoplastic bone marrow, with lymphoid infiltrates. No molecular abnormalities in the BM.
- autoimmune thyroiditis
- vitiligo (as Koebner phenomenon around the warts)
- otherwise healthy, without history of infections in spite of the lymphopenia

Normal Ig, with slightly elevated IgE
IgM 0.6 g/L
IgA 1.05 g/L
IgG 10.2 g/L
IgE 394

Lymphopenia, mainly CD4 with reduced naive compartment, inverted CD4/8 ratio and elevated T g/d lymphocytes.
Lymphocytes 820
T CD4 170
T CD8 326
T GD 159
B 60
NK 28
T CD4 Naive (CD45RA+/CCR7+) 4.9%
T CD4 TEM (CD45RA-/CCR7-) 67.5 %
T CD4 TCM (CD45RA-/CCR7+) 24 %
T CD4 TEMRA (CD45RA+/CCR7-) 3.50%

Reduced TREC, normal KREC

High titer ANA antibodies (>1:640, SP pattern), + anti-Pm/Scl antibodies
Anti-TPO antibodies and anti-TG antibodies

WES found an unreported heterozygous RAG1 mutation, in an highly conserved area of the Zn binding domain, predicted to be damaging.

My questions:

1) How to manage the warts? They are resistant to topical therapies and relapse after surgical excision. Furthermore an high risk HPV strain was isolated, rising serious concerns about cancerous evolution. Interferon was proposed as an option, but we are worried about autoimmune manifestations. Does anyone have any experiences?

2) Have you ever seen this bone marrow picture with RAG mutations?

3) Is there someone (possibly in Italy or Europe) who can evaluate the recombinase activity, to confirm the mutation relevance?

Sorry for the lenghty email, and thanks in advance,
Kind regards,

Dr. Boaz Palterer
Dept. of Clinical and Experimental Medicine
Allergology and Clinical Immunology
University of Florence, Italy
cell. +39 3927169114<tel:+39%20392%20716%209114>
email. boaz.palterer at gmail.com<mailto:boaz.palterer at gmail.com>

---

You are currently subscribed to cis-pidd as: stephan.ehl at uniklinik-freiburg.de<mailto:stephan.ehl at uniklinik-freiburg.de>.

To unsubscribe click here: http://cts.dundee.net/u?id=96396905.c7f19e2786458b3d17c11bb0a69a0a7f&n=T&l=cis-pidd&o=4191238

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to leave-4191238-96396905.c7f19e2786458b3d17c11bb0a69a0a7f at lyris.dundee.net<mailto:leave-4191238-96396905.c7f19e2786458b3d17c11bb0a69a0a7f at lyris.dundee.net>

---

You are currently subscribed to cis-pidd as: luigi.notarangelo2 at nih.gov<mailto:luigi.notarangelo2 at nih.gov>.

To unsubscribe click here: http://cts.dundee.net/u?id=96396777.ceaf29f3e714b483a0a5aecd8ad92646&n=T&l=cis-pidd&o=4191285

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to leave-4191285-96396777.ceaf29f3e714b483a0a5aecd8ad92646 at lyris.dundee.net<mailto:leave-4191285-96396777.ceaf29f3e714b483a0a5aecd8ad92646 at lyris.dundee.net>

---

You are currently subscribed to cis-pidd as: sullivank at email.chop.edu<mailto:sullivank at email.chop.edu>.

To unsubscribe click here: http://cts.dundee.net/u?id=99424140.0252c6305bcec2418e0f99fbf64e026c&n=T&l=cis-pidd&o=4191298

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to leave-4191298-99424140.0252c6305bcec2418e0f99fbf64e026c at lyris.dundee.net<mailto:leave-4191298-99424140.0252c6305bcec2418e0f99fbf64e026c at lyris.dundee.net>


---
You are currently subscribed to cis-pidd as: pagid at list.clinimmsoc.org.
To unsubscribe click here: http://cts.dundee.net/u?id=96396833.5a9591ccd1e327fe6bc4d1543298c482&n=T&l=cis-pidd&o=4191338
or send a blank email to leave-4191338-96396833.5a9591ccd1e327fe6bc4d1543298c482 at lyris.dundee.net
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://pairlist7.pair.net/pipermail/pagid/attachments/20170214/2a6ec018/attachment-0001.html>